Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

The RNA Targeting Small Molecule Drug Discovery Market is poised for growth, driven by demand for treatments targeting cancer ...

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

According to brokerage Jefferies, the average drug development cycle spans 8 to 10 years, with success rates below 10% and ...

Selvita is the first contract research organisation (CRO) to license a Chemical Protein Stability Assay developed and ...

Quantum-enhanced drug discovery emerges as a leading investment trend within the pharmaceutical sector for 2025. Since the ...

The global Drug Discovery Software market valued at ~$2 billion in 2020 and is expected to grow at a CAGR of ~14% to cross $3.5 billion by 2025, driven by growing R&D spending across the world, need ...

Drug discovery, and science in general, are fields built on data. Foundation models bring new capabilities by integrating ...

The collaboration will work with Nuclera’s eProtein TM Discovery System with Cytiva’s ... to these proteins and understanding how they interact with drug candidates is essential for drug development.

Microsoft Scientific Discovery is an AI-powered research-focused platform designed for scientists, research institutions, and ...